Home> Products> titration

{ "products": [ { "_id": "693c0f0df827a9801a26dcd7", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Isosorbide mononitrate IP 60mg Tablets", "description": "CARDULES ISMN SR 60 delivers Isosorbide Mononitrate IP 60mg in a sustained-release tablet form, designed for long-term prevention of angina in patients with coronary artery disease. Produced by Steris Healthcare Pvt Ltd, this formulation ensures steady drug release over 12-24 hours, optimizing cardiovascular protection with once-daily dosing convenience. It supports heart health by enhancing blood flow without the peaks and troughs of immediate-release options.​\n\nProduct Overview\nCARDULES ISMN SR 60 contains Isosorbide Mononitrate IP 60mg per sustained-release tablet, a pure nitrate metabolite that bypasses first-pass liver metabolism for consistent bioavailability. The SR technology employs a polymer matrix to gradually liberate the active ingredient, maintaining therapeutic plasma levels throughout the day and minimizing tolerance development associated with frequent dosing. Available in strips of 10 tablets, it features a film-coated exterior for easy swallowing and gastro-resistant properties to protect against stomach acid degradation.​\n\nThis higher 60mg strength suits patients requiring intensified prophylaxis after initial titration from lower doses like 30mg or 40mg. It integrates seamlessly into comprehensive cardiac regimens alongside beta-blockers, statins, or aspirin, under cardiologist supervision. Quality manufacturing adheres to IP standards, ensuring purity above 99% with low impurity profiles for safety in chronic use.​\n\nKey Uses\nCARDULES ISMN SR 60 primarily prevents chronic stable angina pectoris by dilating coronary arteries and reducing myocardial oxygen demand during exertion. Patients experience fewer episodes of chest tightness, pressure, or discomfort triggered by physical activity, stress, or cold exposure.​\n\nIt manages coronary artery disease (CAD) by improving collateral circulation and easing ischemia in narrowed vessels. Often prescribed post-angioplasty or alongside lifestyle modifications, it stabilizes symptoms for enhanced daily functioning.​\n\nAdditionally, it supports adjunctive therapy in congestive heart failure or post-myocardial infarction recovery, where vasodilation unloads the heart. Not for acute attacks—use sublingual nitroglycerin instead—but vital for long-term risk reduction.​\n\nMajor Benefits\nThe sustained-release profile of CARDULES ISMN SR 60 provides 24-hour angina prevention with single morning dosing, improving adherence over multiple-daily regimens. This steady vasodilation lowers preload via venous pooling and afterload via arterial relaxation, cutting oxygen consumption by up to 20-30% during stress.​\n\nPatients report increased exercise tolerance, with treadmill tests showing delayed onset of ST-segment depression. Enhanced myocardial perfusion boosts energy levels, enabling return to work, hobbies, or family activities without fear of sudden symptoms.​\n\nCompared to shorter-acting nitrates, tolerance buildup is slower due to a nitrate-free interval built into once-daily use. Cost-effective at higher strengths, it reduces overall healthcare visits and hospitalization risks from unstable angina.​\n\nBenefit\tMechanism\tClinical Advantage\nAngina Prevention\tVasodilation reduces preload/afterload ​\tFewer episodes, better quality of life\nExercise Capacity\tImproved coronary flow ​\tExtended activity duration by 50%+\nDosing Simplicity\tSR once daily ​\t90% adherence rate vs. multiple doses\nHeart Protection\tLowers ischemia risk. ​\tReduced MI recurrence\nPotential Side Effects\nCommon effects include headache (orthostatic or throbbing), especially in the first week, resolving with hydration and dose acclimation—acetaminophen helps manage it. Dizziness, lightheadedness, or postural hypotension may occur; rise slowly from sitting.​\n\nGastrointestinal upset like nausea or flushing affects 5-10% initially. Avoid alcohol or PDE5 inhibitors (e.g., sildenafil) to prevent severe hypotension.​\n\nRarely, reflex tachycardia, rash, or methemoglobinemia arises; monitor liver enzymes in prolonged use. Contraindicated in severe anemia, glaucoma, or recent PDE5 intake—discontinue if allergic reactions appear.​\n\nDosage Guidelines\nInitiate at 30-40mg daily, titrating to 60mg once in the morning on an empty stomach for optimal absorption. Swallow whole; do not crush. A 10-12 hour nitrate-free window (nighttime) prevents tolerance.​\n\nAdjust for renal/hepatic impairment; max 120mg/day. Store below 25°C. Regular ECG and BP checks ensure efficacy.​\nConclusion\nCARDULES ISMN SR 60 stands as a cornerstone in angina prophylaxis, empowering CAD patients with reliable, sustained vascular relief from Steris Healthcare. Consistent use alongside diet, exercise, and smoking cessation maximizes outcomes, but cardiologist oversight remains essential for safety", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2244, "imageuri": "https://productimages.withfloats.com/actual/693c0f14d878634fd7a965ca.png", "tileimageuri": "https://productimages.withfloats.com/tile/693c0f14d878634fd7a965ca.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-12T12:48:13.762Z", "updatedon": "2025-12-16T05:41:10.59Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/isosorbide-mononitrate-ip-60mg-tablets/2244", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CARDULES ISMN SR 60", "category": "cardiology", "tags": [ "Isosorbide mononitrate IP 60mg Tablets", "coronary artery disease", "supports heart health by enhancing blood flow", "gastro-resistant properties to protect against stomach acid", "Contraindicated in severe anemia, glaucoma, or recent PDE5" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "693c0c9c0c30ac5c9f8203b4", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Isosorbide Mononitrate IP 30mg Tablets", "description": "CARDULES ISMN SR 30 tablets provide sustained-release Isosorbide Mononitrate IP 30mg, a nitrate medication designed for long-term management of angina in patients with coronary artery disease. This formulation from Steris Healthcare Pvt Ltd ensures steady vasodilation to improve heart blood flow and reduce chest pain episodes. It supports daily activities by minimizing oxygen demand on the heart muscle.​\nProduct Overview\nCARDULES ISMN SR 30 contains Isosorbide Mononitrate IP 30mg in a sustained-release matrix, allowing once-daily dosing for consistent therapeutic levels over 12-24 hours. The tablet's extended-release technology prevents peak-trough fluctuations common in immediate-release forms, promoting better patient compliance. Each film-coated tablet delivers precise bioavailability, with the active metabolite nitric oxide activating guanylate cyclase to boost cyclic GMP, relaxing vascular smooth muscle primarily in veins.​\n\nThis mechanism reduces preload (venous return to the heart) and afterload (arterial resistance), easing cardiac workload without significantly affecting heart rate. Unlike short-acting nitrates for acute relief, CARDULES ISMN SR 30 targets prophylaxis in chronic stable angina, often prescribed alongside beta-blockers or calcium channel blockers. Available in strips of 10 tablets, it undergoes rigorous quality testing at Steris facilities to meet IP standards, ensuring purity and stability.​\n\nKey Uses\nCARDULES ISMN SR 30 primarily prevents angina pectoris in coronary artery disease, where narrowed vessels limit oxygen supply during exertion. Patients experience fewer chest pain attacks during walking, climbing stairs, or stress.​\n\nIt manages chronic stable angina by enhancing myocardial perfusion, suitable for long-term therapy in adults over 18. Healthcare providers may use it adjunctively for coronary spasm or post-myocardial infarction prophylaxis to stabilize symptoms.​\n\nIn select cases, it aids heart failure management by offloading the heart, though not as monotherapy. Always initiate under cardiology supervision with dose titration to tolerance.​\n\nMajor Benefits\nThe sustained-release profile offers 24-hour protection with single morning dosing, improving adherence and lifestyle quality for active patients. It boosts exercise tolerance by 20-30% in trials, allowing longer physical efforts without angina onset.​\n\nBy dilating vessels, it decreases ischemia risk, potentially lowering hospitalization rates for acute episodes. Compared to placebo, users report halved attack frequency within weeks, enhancing daily productivity and emotional well-being.​\n\nBenefit\tMechanism\tPatient Outcome\nAngina Prevention\tVasodilation reduces preload/afterload ​\tFewer attacks, better exertion capacity\nSteady Relief\tSR formulation maintains levels ​\tOnce-daily convenience, no fluctuations\nHeart Protection\tImproves O2 delivery ​\tReduced ischemia, enhanced QoL\nCompliance Boost\tSimple regimen ​\tHigher adherence vs multiple doses\nAdditional perks include minimal impact on blood pressure in normotensives and compatibility with anti-anginals, making it versatile in combo therapy.\n\nPotential Side Effects\nCommon effects include headache (dose-related, often transient in first week), dizziness, or flushing due to vasodilation—hydrate and rise slowly to manage. Gastrointestinal upset like nausea occurs in 5-10% initially.​\n\nOrthostatic hypotension risks fainting, especially early; avoid alcohol or other vasodilators. Rare serious issues encompass severe hypotension, tachycardia, or methemoglobinemia with overdose—monitor blood pressure regularly.​\n\nAllergic reactions (rash, itching) or vision changes warrant discontinuation. Contraindicated in hypotension, glaucoma, or recent PDE5 inhibitor use; caution in anemia or hypothyroidism.​\n\nDosage Guidelines\nStart with 30mg once daily upon waking, swallowed whole without crushing. Titrate to 60mg if tolerated after 3-7 days, max 120mg/day. Take on empty stomach for optimal absorption; avoid late dosing to prevent nocturnal headaches.​\n\nAdjust for elderly or renal/hepatic impairment. Tolerance may develop—nitrate-free interval (evening) helps sustain efficacy. Store below 30°C.​\nConclusion\nCARDULES ISMN SR 30 empowers angina patients with reliable, once-daily prevention, restoring confidence in routine activities under Steris Healthcare's quality assurance. Its targeted vasodilation balances efficacy and tolerability for sustained heart health", "price": 65.0, "discountamount": 19.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2243, "imageuri": "https://productimages.withfloats.com/actual/693c0ca6391a3fa44b0608d8.png", "tileimageuri": "https://productimages.withfloats.com/tile/693c0ca6391a3fa44b0608d8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-12T12:37:48.92Z", "updatedon": "2025-12-12T12:37:48.92Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/isosorbide-mononitrate-ip-30mg-tablets/2243", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CARDULES ISMN SR 30", "category": "", "tags": [ "Isosorbide Mononitrate IP 30mg Tablets", "coronary artery disease", "heart blood flow and reduce chest pain episodes", "oxygen demand on the heart muscle", "relaxing vascular smooth muscle primarily in veins" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "693c0a0eb7439f8802544bc8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "RIBAVIRIN CAPSULES IP 100mg", "description": "REBATERIS 100 contains Ribavirin IP 100mg in a hard gelatin capsule filled with white to off-white powder for optimal stability and bioavailability. Each pack typically includes 30 capsules, designed for oral administration with food to enhance absorption and reduce gastrointestinal upset. Ribavirin, a synthetic guanosine nucleoside analog, interferes with viral RNA polymerase and mRNA capping, halting hepatitis C virus (HCV) replication at multiple stages. This broad-spectrum antiviral also shows activity against respiratory syncytial virus (RSV) in select pediatric cases, though its primary indication remains HCV genotype management.​\n\nThe 100mg strength allows for weight-based dosing adjustments, making REBATERIS 100 suitable for adults and children over 3 years under specialist supervision. Unlike higher 200mg capsules, it supports finer dose reductions during therapy to manage side effects, ensuring better tolerability. Stored at room temperature away from moisture, it maintains potency for extended shelf life, aligning with pharmacopeial standards for purity and dissolution.​\n\nKey Uses\nREBATERIS 100 treats chronic hepatitis C virus infection in combination therapies, particularly for patients ineligible for all-oral direct-acting antivirals. It boosts sustained virologic response rates when paired with pegylated interferon alfa, addressing genotypes 1 through 6 based on regional guidelines.​\n\nIn severe RSV lower respiratory tract infections, off-label use occurs in hospitalized infants, where aerosolized forms predominate, but oral REBATERIS 100 contributes to interferon combos for immunocompromised children. It curbs viral load, prevents liver fibrosis progression, and reduces cirrhosis risk, making it essential for long-term liver preservation.​\n\nAdditionally, emerging evidence supports its adjunct role in certain hemorrhagic fevers like Lassa virus, though availability limits widespread application. Always initiated by hepatologists, treatment durations span 24-48 weeks depending on genotype, viral load, and response milestones.​\n\nMajor Benefits\nREBATERIS 100 enhances viral clearance, achieving up to 50-80% sustained response rates in interferon combinations, significantly lowering hepatocellular carcinoma risk over five years. Patients experience normalized liver enzymes and fibrosis regression on biopsy follow-up.​\n\nIts oral capsule form simplifies adherence compared to injectables, with twice-daily dosing fitting daily routines. The 100mg potency permits precise titration—e.g., 800-1400mg daily divided—for personalized therapy, minimizing excess exposure in lighter patients.​\n\nLong-term, it preserves liver function, averting transplants and improving quality of life metrics like fatigue reduction and work productivity. Cost-effective for resource-limited settings, REBATERIS 100 bridges gaps until pan-genotypic regimens become accessible.​\nBenefit\tMechanism\tClinical Impact\nViral Suppression\tRNA polymerase inhibition ​\t>50% SVR in combos ​\nLiver Protection\tFibrosis halt ​\tReduced cirrhosis by 30-40%\nFlexible Dosing\t100mg increments ​\tBetter tolerability, adherence\nBroad Genotype Coverage\tMulti-genotype efficacy ​\tVersatile for diverse patients\nPotential Side Effects\nCommon side effects include hemolytic anemia, peaking at weeks 4-8, necessitating hemoglobin monitoring and dose cuts to 600mg daily if levels drop below 10g/dL. Fatigue, headache, and insomnia affect over 40% of users, often resolving post-therapy.​\n\nGastrointestinal issues like nausea, diarrhea, and anorexia occur in 20-30%, mitigated by food intake. Dermatologic reactions—rash, pruritus—or flu-like symptoms from interferon pairing demand vigilance. Teratogenicity risks are high; dual contraception is mandatory for 6 months post-treatment due to sperm/ovum mutagenicity.​\n\nSerious risks encompass pulmonary infiltrates, cardiac ischemia in vulnerable patients, and thyroid dysfunction. Avoid in hemoglobinopathies, severe renal impairment (CrCl <50mL/min), or pregnancy. Regular blood counts and ophthalmologic exams guide safe continuation.​\n\nDosage Guidelines\nDosing is weight-based: adults <75kg receive mg/day (10 capsules: 5 AM, 5 PM); ≥75kg get 1200 mg/day (12 capsules: 6 AM, 6 PM), swallowed whole with meals. Pediatrics (≥3 years): 15mg/kg/day divided BID, rounded to the nearest 100mg via REBATERIS 100 capsules.​\n\nReduce by 200-400mg for anemia or neutropenia; discontinue if unresolved. Duration: 48 weeks for genotype 1, 24 weeks for others, with viral load checks at week 12. Swallow intact; no crushing.​\nConclusion\nREBATERIS 100 empowers hepatitis C management with proven antiviral potency and dosing precision from Steris Healthcare. It transforms prognosis for countless patients, but demands specialist oversight amid monitoring needs", "price": 2900.0, "discountamount": 870.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2242, "imageuri": "https://productimages.withfloats.com/actual/693c0a151c130ff8f4cd2c93.png", "tileimageuri": "https://productimages.withfloats.com/tile/693c0a151c130ff8f4cd2c93.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-12T12:26:54.651Z", "updatedon": "2025-12-12T12:26:54.651Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ribavirin-capsules-ip-100mg/2242", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "REBATERIS 100", "category": "Gastroenterology", "tags": [ "Ribavirin IP 100mg", "HCV genotype management", "hepatitis C virus (HCV)", "RNA polymerase and mRNA capping", "respiratory tract infections", "fibrosis progression", "enzymes and fibrosis regression on biopsy" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69282c091a6e5ed700f07fe1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Lurasidone Hydrochloride Tablets 40 mg", "description": "Lurasidone Hydrochloride Tablets 40 mg are an atypical antipsychotic medication primarily prescribed for the treatment of schizophrenia and bipolar disorder, including depressive episodes associated with bipolar I disorder. Manufactured to deliver precise dosing, these tablets help manage symptoms such as hallucinations, delusions, mood swings, and depression by modulating the activity of certain neurotransmitters in the brain. Lurasidone works by balancing dopamine and serotonin receptors, which are often dysregulated in psychiatric conditions, thereby improving thought processes, mood stability, and overall mental function.\nKey Benefits of Lurasidone Hydrochloride Tablets 40 mg\nEffective control of schizophrenia symptoms such as delusions, hallucinations, and disorganized thinking.\nTreatment of major depressive episodes in bipolar I disorder either as monotherapy or adjunctive therapy with lithium or valproate.\nImprovement in mood stabilization helps reduce manic and depressive episodes in bipolar patients.\nGenerally improved patient quality of life by reducing the severity of psychotic and mood symptoms.\nSuitable for adult patients as well as adolescents aged 13 years and older for schizophrenia and patients 10 years and older for bipolar depression under medical guidance.\nFlexible dosing options allow for titration based on clinical response and tolerability.\nSide Effects of Lurasidone Hydrochloride Tablets 40 mg\nLike many antipsychotic medications, Lurasidone may cause side effects, some of which are mild and manageable, while others may require medical attention. Common side effects include nausea, dizziness, restlessness, sedation, weight gain, and gastrointestinal issues such as vomiting or constipation. Some patients may experience extrapyramidal symptoms, which affect muscle control and movement, such as tremors or rigidity. Blood sugar and lipid levels may rise, so periodic monitoring is advised.\nSerious side effects, though less common, can include neuroleptic malignant syndrome (a rare but severe neurological disorder), tardive dyskinesia (involuntary muscle movements), and metabolic changes like significant weight gain, hyperglycemia, or elevated cholesterol. Allergic reactions are rare but possible and require immediate medical attention.\n\nConclusion\n\nLurasidone Hydrochloride Tablets 40 mg offer significant benefits for patients struggling with schizophrenia and bipolar depression by addressing psychotic symptoms and mood disturbances through targeted neurotransmitter modulation. Its efficacy in improving mental health and quality of life is well-documented, but careful adherence to prescribed dosages and medical supervision are essential due to potential side effects. Regular monitoring and open communication with healthcare providers help ensure that patients receive the maximum therapeutic benefit while minimizing risks. This medication should always be used under the guidance of a qualified healthcare professional.", "price": 280.0, "discountamount": 84.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2222, "imageuri": "https://productimages.withfloats.com/actual/69282c0bb521bb4f16017ce2.png", "tileimageuri": "https://productimages.withfloats.com/tile/69282c0bb521bb4f16017ce2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-27T10:46:33.864Z", "updatedon": "2025-12-01T09:14:37.234Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/lurasidone-hydrochloride-tablets-40-mg/2222", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LURASINODE 40", "category": "", "tags": [ "Lurasidone Hydrochloride Tablets 40 mg", "schizophrenia and bipolar disorder", "Lurasidone", "bipolar I disorder" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666be1f505b00e1ad41ca281", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "RISPERIDIN 4 ", "description": "RISPERIDIN 4 \nRisperidone (4mg)\nIntroduction:\n\nRisperidin 4 contains Risperidone at a 4mg dosage, an effective second-generation antipsychotic used to manage various psychiatric disorders. This medication is renowned for its ability to treat conditions such as schizophrenia, bipolar disorder, and certain behavioral disturbances, offering significant improvements in patients' quality of life.\nKey Features and Benefits:\n\nAntipsychotic Efficacy:\n\nRisperidin 4 works by antagonizing dopamine and serotonin receptors in the brain, which helps reduce psychotic symptoms like hallucinations, delusions, and disorganized thinking commonly associated with schizophrenia.\nMood Stabilization:\n\nIn bipolar disorder, Risperidin 4 plays a crucial role in stabilizing mood swings. It effectively reduces the severity and frequency of manic episodes and helps prevent depressive relapses, promoting emotional stability.\nBehavioral Improvement:\n\nFor individuals with behavioral disturbances, such as those seen in autism spectrum disorders or dementia, Risperidin 4 helps mitigate aggression, agitation, and irritability, thereby improving social interactions and overall behavior.\nCognitive Function:\n\nSome studies suggest that Risperidin 4 can enhance cognitive functions in certain patients, improving aspects like attention, executive function, and overall cognitive performance.\nDosage and Administration:\n\nInitial Dosage:\nThe starting dose of Risperidin 4 is typically 4mg once daily, taken orally with or without food. Dosage adjustments should be based on individual clinical response and tolerability.\nTitration and Maintenance:\nGradual titration of the dosage may be necessary to achieve the desired therapeutic effect while minimizing side effects. Maintenance doses are personalized to each patient’s needs and therapeutic goals.\nMonitoring:\nRegular monitoring of psychiatric symptoms, mood stability, and potential side effects is essential throughout the treatment to ensure the effectiveness and safety of Risperidin 4.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/risperidin-4-133626", "price": 91.0, "discountamount": 28.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "life", "food", "brain", "EMAIL", "needs", "safety", "product", "studies", "aspects", "dopamine", "Benefits", "severity", "dementia", "delusions", "frequency", "attention", "treatment", "agitation", "conditions", "medication", "4mg dosage", "aggression", "RISPERIDIN", "information", "mood swings", "Risperidone", "individuals", "Introduction", "sterispharma", "sterisonline", "Key Features", "irritability", "crucial role", "tolerability", "CALL/WHATSAPP", "effectiveness", "schizophrenia", "starting dose", "Administration", "manic episodes", "Initial Dosage", "mood stability", "hallucinations", "bipolar disorder", "overall behavior", "therapeutic goals", "Maintenance doses", "Gradual titration", "patients' quality", "Regular monitoring", "therapeutic effect", "executive function", "Mood Stabilization", "psychotic symptoms", "Dosage adjustments", "Cognitive Function", "social interactions", "emotional stability", "depressive relapses", "serotonin receptors", "psychiatric symptoms", "disorganized thinking", "Behavioral Improvement", "Antipsychotic Efficacy", "potential side effects", "behavioral disturbances", "significant improvements", "autism spectrum disorders", "individual clinical response", "various psychiatric disorders", "overall cognitive performance", "effective second-generation antipsychotic" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1891, "imageuri": "https://productimages.withfloats.com/actual/666be1f8492d7ea0aba14bdd.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666be1f8492d7ea0aba14bdd.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T06:23:49.795Z", "updatedon": "2025-12-12T07:59:37.421Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/risperidin-4-/1891", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "RISPERIDIN 4 ", "category": "NEUROLOGY RANGE", "tags": [ "risperidone 4 mg price", "risperidone side effects", "RISPERIDIN 4", "risperidone 4 mg uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666ae5c5ca84cd189c25cbff", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "rasagiline 0.5 mg", "description": "Rasagail 0.5 \nRasagiline (0.5mg)\nIntroduction:\n\nRasagail 0.5 encapsulates the medicinal prowess of Rasagiline, a potent and selective monoamine oxidase-B (MAO-B) inhibitor used in the management of Parkinson's disease. With a dosage strength of 0.5mg, Rasagail 0.5 aims to optimize neurological function and enhance quality of life for individuals battling Parkinson's disease.\nKey Features and Benefits:\nMAO-B Inhibition:\nRasagail 0.5 exerts its therapeutic effects by selectively inhibiting MAO-B enzymes, thereby increasing dopamine levels in the brain's striatum. This mechanism helps alleviate motor symptoms and improve motor function in Parkinson's disease.\nNeuroprotective Properties:\n\nBeyond symptomatic relief, Rasagail 0.5 offers neuroprotective benefits by reducing oxidative stress, preventing neuronal damage, and potentially slowing disease progression in Parkinson's patients.\nEnhanced Dopaminergic Transmission:\n\nBy enhancing dopaminergic neurotransmission, Rasagail 0.5 contributes to smoother motor coordination, reduced rigidity, tremors, and bradykinesia, fostering greater mobility and independence.\nAdjunctive Therapy:\n\nRasagail 0.5 can be used as monotherapy in early-stage Parkinson's disease or as an adjunct to levodopa/carbidopa in advanced stages, providing a comprehensive approach to symptom management.\nDosage and Administration:\n\nInitial Dosage:\nThe recommended starting dose of Rasagail 0.5 is 0.5mg once daily, taken orally with or without food. Dosage adjustments may be made based on individual patient response and tolerability.\nTitration and Maintenance:\nGradual titration may occur as directed by healthcare providers to achieve optimal therapeutic benefits while minimizing side effects. Maintenance doses are typically tailored to individual patient needs.\nContinued Monitoring:\nRegular clinical assessments and monitoring of Parkinson's disease symptoms, motor function, and potential adverse effects are essential components of Rasagail 0.5 therapy to ensure treatment efficacy and safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 70.0, "discountamount": 2.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "food", "life", "EMAIL", "Order", "0.5mg", "brain", "safety", "tremors", "quality", "striatum", "rigidity", "patients", "carbidopa", "mechanism", "Rasagiline", "monotherapy", "information", "individuals", "Introduction", "sterisonline", "Key Features", "bradykinesia", "independence", "side effects", "tolerability", "sterispharma", "CALL/WHATSAPP", "MAO-B enzymes", "starting dose", "Administration", "Initial Dosage", "motor function", "motor symptoms", "dopamine levels", "dosage strength", "neuronal damage", "advanced stages", "MAO-B) inhibitor", "oxidative stress", "greater mobility", "MAO-B Inhibition", "disease symptoms", "Maintenance doses", "medicinal prowess", "Gradual titration", "Adjunctive Therapy", "symptom management", "Dosage adjustments", "treatment efficacy", "symptomatic relief", "therapeutic effects", "disease progression", "essential components", "healthcare providers", "Rasagail 0.5 therapy", "Continued Monitoring", "neurological function", "early-stage Parkinson", "comprehensive approach", "neuroprotective benefits", "individual patient needs", "potential adverse effects", "Neuroprotective Properties", "individual patient response", "smoother motor coordination", "optimal therapeutic benefits", "Regular clinical assessments", "selective monoamine oxidase-B", "dopaminergic neurotransmission", "Enhanced Dopaminergic Transmission" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1887, "imageuri": "https://productimages.withfloats.com/actual/666ae5c88c6c791fd3b65cab.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666ae5c88c6c791fd3b65cab.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T12:27:49.832Z", "updatedon": "2025-12-12T07:40:15.648Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/rasagiline-0-5-mg/1887", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Rasagail 0.5 ", "category": "NEUROLOGY RANGE", "tags": [ "rasagiline side effects", "rasagiline benefits", "long-term side effects of rasagiline", "rasagiline uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666a9bf44722330554e90097", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LAMOTROZEN 25 ", "description": "LAMOTROZEN 25 \nLamotrigine (25mg)\nIntroduction:\n\nLAMOTROZEN 25 contains Lamotrigine (25 mg), a versatile antiepileptic medication used to treat partial-onset seizures, generalized seizures of Lennox-Gastaut syndrome, and primary generalized tonic-clonic seizures. Additionally, it is prescribed for the maintenance treatment of bipolar disorder to prevent mood episodes.\nKey Features and Benefits:\n\nSeizure Control: Lamotrigine is effective in reducing the frequency and severity of various types of seizures, including partial-onset seizures and generalized seizures, providing better control over epileptic conditions.\nBipolar Disorder Management: Lamotrigine helps prevent mood episodes in individuals with bipolar disorder, stabilizing mood and reducing the risk of extreme mood swings.\nNeurostabilization: It works by inhibiting voltage-sensitive sodium channels, which stabilizes neuronal membranes and prevents excessive neuronal firing, thereby reducing seizure activity and mood instability.\nConvenient Dosage: The 25 mg strength allows for flexible dosing schedules and adjustments as needed by healthcare providers to achieve optimal therapeutic effects.\nDosage and Administration:\n\nInitial Dosage for Epilepsy: The typical starting dose of LAMOTROZEN 25 (Lamotrigine 25 mg) is usually initiated at a low dose and gradually increased. The starting dose may vary depending on whether Lamotrigine is used alone or in combination with other antiepileptic drugs.\nInitial Dosage for Bipolar Disorder: For bipolar disorder, the initial dose is typically lower and gradually increased according to a titration schedule determined by a healthcare provider.\nMaintenance Dosage: The maintenance dose for epilepsy generally ranges from 100 mg to 500 mg per day, divided into two doses. For bipolar disorder, the maintenance dose typically ranges from 100 mg to 400 mg per day.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Lamotrigine at the same times each day to maintain consistent medication levels in the bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/lamotrozen-50-134352\n", "price": 85.0, "discountamount": 25.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "food", "risk", "EMAIL", "water", "500 mg", "400 mg", "100 mg", "tablet", "Benefits", "low dose", "severity", "Epilepsy", "two doses", "frequency", "LAMOTROZEN", "same times", "adjustments", "combination", "individuals", "bloodstream", "information", "sterispharma", "Introduction", "sterisonline", "Key Features", "initial dose", "various types", "mood episodes", "CALL/WHATSAPP", "Initial Dosage", "25 mg strength", "Administration", "Seizure Control", "seizure activity", "maintenance dose", "mood instability", "Convenient Dosage", "Lamotrigine 25 mg", "Maintenance Dosage", "titration schedule", "Neurostabilization", "neuronal membranes", "extreme mood swings", "healthcare providers", "epileptic conditions", "generalized seizures", "maintenance treatment", "typical starting dose", "partial-onset seizures", "Lennox-Gastaut syndrome", "excessive neuronal firing", "flexible dosing schedules", "other antiepileptic drugs", "Bipolar Disorder Management", "optimal therapeutic effects", "consistent medication levels", "voltage-sensitive sodium channels", "versatile antiepileptic medication", "primary generalized tonic-clonic seizures" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1844, "imageuri": "https://productimages.withfloats.com/actual/666a9bf70b4fc76a99a1fbd0.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/666a9bf70b4fc76a99a1fbd0.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T07:12:52.134Z", "updatedon": "2024-06-26T10:49:06.365Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/lamotrozen-25-/1844", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LAMOTROZEN 25 ", "category": "NEUROLOGYRANGE", "tags": [ "Lamotrigine (25mg)", "", "lamotrigine side effects", "lamotrigine side effects weight gain", "lamictal weight gain reviews", "lamotrigine uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666a99b5c91739182c956027", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LAMOTRIZ 50 ", "description": "LAMOTRIZ 50 \nLamotrigine Dispersible 50\nIntroduction:\n\nLAMOTRIZ 50 contains Lamotrigine Dispersible (50 mg), a versatile antiepileptic medication used to treat partial-onset seizures, generalized seizures of Lennox-Gastaut syndrome, and primary generalized tonic-clonic seizures. Additionally, it is prescribed for the maintenance treatment of bipolar disorder to prevent mood episodes.\nKey Features and Benefits:\n\nSeizure Control: Lamotrigine is effective in reducing the frequency and severity of various types of seizures, including partial-onset seizures and generalized seizures, providing better control over epileptic conditions.\nBipolar Disorder Management: Lamotrigine helps prevent mood episodes in individuals with bipolar disorder, stabilizing mood and reducing the risk of extreme mood swings.\nNeurostabilization: It works by inhibiting voltage-sensitive sodium channels, which stabilizes neuronal membranes and prevents excessive neuronal firing, thereby reducing seizure activity and mood instability.\nDispersible Tablet: The dispersible formulation of Lamotrigine makes it easier to administer, especially for individuals who have difficulty swallowing tablets. It can be dissolved in water or placed on the tongue to dissolve.\nDosage and Administration:\n\nInitial Dosage for Epilepsy: The typical starting dose of LAMOTRIZ 50 (Lamotrigine Dispersible 50 mg) is usually initiated at a low dose and gradually increased. The starting dose may vary depending on whether Lamotrigine is used alone or in combination with other antiepileptic drugs.\nInitial Dosage for Bipolar Disorder: For bipolar disorder, the initial dose is typically lower and gradually increased according to a titration schedule determined by a healthcare provider.\nMaintenance Dosage: The maintenance dose for epilepsy generally ranges from 100 mg to 500 mg per day, divided into two doses. For bipolar disorder, the maintenance dose typically ranges from 100 mg to 400 mg per day.\nAdministration: The dispersible tablet should be placed on the tongue to dissolve or mixed with a small amount of water before swallowing. It can be taken with or without food.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/lamotriz-50-133579", "price": 108.8, "discountamount": 32.64, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "risk", "food", "EMAIL", "water", "100 mg", "500 mg", "400 mg", "tongue", "tablets", "product", "low dose", "severity", "Benefits", "LAMOTRIZ", "Epilepsy", "frequency", "two doses", "difficulty", "individuals", "combination", "information", "sterisonline", "Introduction", "sterispharma", "small amount", "Key Features", "initial dose", "CALL/WHATSAPP", "various types", "mood episodes", "Initial Dosage", "Administration", "Seizure Control", "mood instability", "seizure activity", "maintenance dose", "neuronal membranes", "Dispersible Tablet", "titration schedule", "Maintenance Dosage", "Neurostabilization", "extreme mood swings", "healthcare provider", "generalized seizures", "epileptic conditions", "typical starting dose", "maintenance treatment", "partial-onset seizures", "dispersible formulation", "Lennox-Gastaut syndrome", "excessive neuronal firing", "other antiepileptic drugs", "Bipolar Disorder Management", "Lamotrigine Dispersible 50 mg", "voltage-sensitive sodium channels", "versatile antiepileptic medication", "primary generalized tonic-clonic seizures" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1843, "imageuri": "https://productimages.withfloats.com/actual/666a99b84b514c761a3042cc.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666a99b84b514c761a3042cc.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T07:03:17.643Z", "updatedon": "2024-06-26T10:48:08.273Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/lamotriz-50-/1843", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LAMOTRIZ 50 ", "category": "NEUROLOGYRANGE", "tags": [ "LAMOTRIZ 50", "", "Lamotrigine Dispersible 50", "", "lamotrigine 50 mg uses", "lamotrigine side effects", "lamotrigine side effects weight gain", "bipolar weight gain solutions" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666a9788c4201222ec3495de", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LAMOTRIZ 25", "description": "LAMOTRIZ 25\nLamotrigine Dispersible 25\nIntroduction:\n\nLAMOTRIZ 25 contains Lamotrigine Dispersible (25 mg), a versatile antiepileptic medication used to treat partial-onset seizures, generalized seizures of Lennox-Gastaut syndrome, and primary generalized tonic-clonic seizures. Additionally, it is prescribed for the maintenance treatment of bipolar disorder to prevent mood episodes.\nKey Features and Benefits:\n\nSeizure Control: Lamotrigine is effective in reducing the frequency and severity of various types of seizures, including partial-onset seizures and generalized seizures, providing better control over epileptic conditions.\nBipolar Disorder Management: Lamotrigine helps prevent mood episodes in individuals with bipolar disorder, stabilizing mood and reducing the risk of extreme mood swings.\nNeurostabilization: It works by inhibiting voltage-sensitive sodium channels, which stabilizes neuronal membranes and prevents excessive neuronal firing, thereby reducing seizure activity and mood instability.\nDispersible Tablet: The dispersible formulation of Lamotrigine makes it easier to administer, especially for individuals who have difficulty swallowing tablets. It can be dissolved in water or placed on the tongue to dissolve.\nDosage and Administration:\n\nInitial Dosage for Epilepsy: The typical starting dose of LAMOTRIZ 25 (Lamotrigine Dispersible 25 mg) is usually initiated at a low dose and gradually increased. The starting dose may vary depending on whether Lamotrigine is used alone or in combination with other antiepileptic drugs.\nInitial Dosage for Bipolar Disorder: For bipolar disorder, the initial dose is typically lower and gradually increased according to a titration schedule determined by a healthcare provider.\nMaintenance Dosage: The maintenance dose for epilepsy generally ranges from 100 mg to 500 mg per day, divided into two doses. For bipolar disorder, the maintenance dose typically ranges from 100 mg to 400 mg per day.\nAdministration: The dispersible tablet should be placed on the tongue to dissolve or mixed with a small amount of water before swallowing. It can be taken with or without food.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/lamotriz-25-133578", "price": 53.0, "discountamount": 15.9, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "risk", "food", "EMAIL", "water", "100 mg", "500 mg", "400 mg", "tongue", "tablets", "product", "low dose", "severity", "Benefits", "LAMOTRIZ", "Epilepsy", "frequency", "two doses", "difficulty", "individuals", "combination", "information", "sterisonline", "Introduction", "sterispharma", "small amount", "Key Features", "initial dose", "CALL/WHATSAPP", "various types", "mood episodes", "Initial Dosage", "Administration", "Seizure Control", "mood instability", "seizure activity", "maintenance dose", "neuronal membranes", "Dispersible Tablet", "titration schedule", "Maintenance Dosage", "Neurostabilization", "extreme mood swings", "healthcare provider", "generalized seizures", "epileptic conditions", "typical starting dose", "maintenance treatment", "partial-onset seizures", "dispersible formulation", "Lennox-Gastaut syndrome", "excessive neuronal firing", "other antiepileptic drugs", "Bipolar Disorder Management", "Lamotrigine Dispersible 25 mg", "voltage-sensitive sodium channels", "versatile antiepileptic medication", "primary generalized tonic-clonic seizures" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1842, "imageuri": "https://productimages.withfloats.com/actual/666a978b844f260024683cbf.png", "tileimageuri": "https://productimages.withfloats.com/tile/666a978b844f260024683cbf.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T06:54:00.023Z", "updatedon": "2024-06-26T10:47:13.635Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/lamotriz-25/1842", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LAMOTRIZ 25", "category": "NEUROLOGYRANGE", "tags": [ "Lamotrigine Dispersible 25", "", "lamotrigine dispersible tablets uses", "lamotrigine dispersible tablets ip 25 mg", "lamictal chewable tablets dosage", "lamictal dosage for depression" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }